Arcutis Biotherapeutics (NASDAQ:ARQT) is gearing up to announce its quarterly earnings on Wednesday, 2026-02-25. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Arcutis Biotherapeutics will report an earnings per share (EPS) of $0.07.
The market awaits Arcutis Biotherapeutics’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings Track Record
Last quarter the company beat EPS by $0.16, which was followed by a 1.36% increase in the share price the next day.
Here’s a …